These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37814691)

  • 1. Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns.
    Gottlieb J; Linehan J; Murray KS
    Transl Androl Urol; 2023 Sep; 12(9):1449-1455. PubMed ID: 37814691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
    Linehan J; Gottlieb J; Woldu SL; Labbate C; Rose K; Sexton W; Kaimakliotis H; Jacob J; Dickstein R; Nieder A; Bjurlin M; Humphreys M; Ghodoussipor S; Quek M; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y; Murray KS
    Eur Urol Focus; 2023 Nov; 9(6):1052-1058. PubMed ID: 37263827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
    Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
    Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma.
    Kokorovic A; Matin SF
    Ther Adv Med Oncol; 2020; 12():1758835920937950. PubMed ID: 32670424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
    Kleinmann N; Matin SF; Pierorazio PM; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky S; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Stern J; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Adibi M; Amin MB; Seltzer E; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Schoenberg M; Lerner SP
    Lancet Oncol; 2020 Jun; 21(6):776-785. PubMed ID: 32631491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
    Woldu SL; Labbate C; Murray KS; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour S; Quek ML; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y
    Urol Oncol; 2023 Mar; 41(3):147.e15-147.e21. PubMed ID: 36424224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma.
    Metcalf M; Pierorazio PM
    Transl Androl Urol; 2020 Aug; 9(4):1831-1840. PubMed ID: 32944547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of mitomycin-containing reverse thermal gel for the treatment of low-grade upper tract urothelial carcinoma.
    Head DJ; Raman JD
    Expert Rev Anticancer Ther; 2024 Oct; 24(10):943-948. PubMed ID: 39129535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
    Rosen GH; Nallani A; Muzzey C; Murray KS
    J Urol; 2022 Jun; 207(6):1302-1311. PubMed ID: 35130080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Intraluminal Therapies in Upper Tract Urothelial Carcinoma: A Narrative Review.
    Tyrrell J; Chui W; Kealey J; Sengupta S
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
    Matin SF; Pierorazio PM; Kleinmann N; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky SG; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Seltzer E; Schoenberg M; Lerner SP
    J Urol; 2022 Apr; 207(4):779-788. PubMed ID: 34915741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and MetaAnalysis of Available Evidence.
    Ali Deb A; Chitteti P; Naushad N; Asaad W; Leung S; Alice H; Hosam S
    Urol Res Pract; 2024 Mar; 50(2):72-84. PubMed ID: 39145764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Local Agents for the Treatment of Localized Upper Tract Urothelial Carcinoma: A Review of the Current Evidence.
    Asimakopoulos AD; Kochergin M; Klöcker C; Gakis G
    Bladder Cancer; 2023; 9(1):15-27. PubMed ID: 38994483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Low-grade Upper Tract Urothelial Carcinoma: An Unmet Need.
    Raman J; Shore ND
    Rev Urol; 2020; 22(1):1-8. PubMed ID: 32523465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
    Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
    Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant intraluminal therapies for upper tract urothelial carcinoma.
    Khargi R; Connors C; Ricapito A; Yaghoubian AJ; Gallante BE; Khusid JA; Atallah WM; Gupta M
    Transl Androl Urol; 2023 Sep; 12(9):1439-1448. PubMed ID: 37814698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies.
    Ham WS; Park JS; Jang WS; Kim J
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.